Cano Health Inc. (CANO)
NYSE: CANO
· Real-Time Price · USD
2.30
-0.05 (-2.13%)
At close: Feb 02, 2024, 10:00 PM
Cano Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 788.07M | 766.75M | 866.91M | 680.37M | 665.03M | 689.37M | 704.34M | 492.25M | 526.8M | 393.16M | 280.13M |
Cost of Revenue | 772.47M | 826.39M | 776.76M | 573.37M | 553.43M | 593.96M | 596.46M | 422.01M | 437.02M | 335.6M | 229.33M |
Gross Profit | 15.6M | -59.64M | 90.15M | 107M | 111.6M | 95.41M | 107.88M | 70.24M | 89.77M | 57.56M | 50.8M |
Operating Income | -466.92M | -245.63M | -33.54M | -26.42M | -25.15M | -30.61M | -7.74M | -42.26M | -9.63M | -13.33M | 869K |
Interest Income | 258K | 90K | 9K | 7K | 4K | 2K | 1K | n/a | 1K | 1K | 1K |
Pretax Income | -491.84M | -272.62M | -60.59M | -300.21M | -113.26M | -13.76M | 995K | 1.28M | -40.34M | 2.92M | -9.76M |
Net Income | -260.49M | -140.75M | -28.15M | -301.73M | -112.01M | -14.56M | -85K | 661K | -14.64M | 9.48M | -10.47M |
Selling & General & Admin | 80.82M | 99.42M | 96.47M | 107.83M | 111.77M | 106.18M | 96.59M | 93.35M | 75.93M | 46.57M | 35.29M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -900K | 1.32M | 27.22M | 26.42M | 25.34M | 19.84M | 19.04M | 6K | -29K | -25K | 5.85M |
Operating Expenses | 107.56M | 188.67M | 123.69M | 134.25M | 137.11M | 126.02M | 115.62M | 112.04M | 92.88M | 54.52M | 41.13M |
Interest Expense | 29.65M | 26.72M | 23.5M | 19.63M | 16.45M | 13.13M | 13.28M | 14.93M | 16.02M | 9.71M | 10.63M |
Selling & Marketing Expenses | n/a | n/a | n/a | 11.24M | n/a | n/a | n/a | -64.16M | n/a | n/a | n/a |
Cost & Expenses | 880.03M | 1.02B | 900.45M | 707.62M | 690.54M | 719.98M | 712.08M | 534.05M | 529.9M | 390.12M | 270.46M |
Income Tax Expense | -145K | -1.87M | -32.44M | 1.52M | -1.25M | 809K | 1.08M | 776K | 547K | -2.02M | 714K |
Shares Outstanding (Basic) | 5.28M | 5.28M | 5.03M | 4.89M | 4.89M | 4.75M | 4.68M | 1.78M | 1.71M | 1.67M | 1.66M |
Shares Outstanding (Diluted) | 5.28M | 5.28M | 5.03M | 4.89M | 4.89M | 4.75M | 4.68M | 1.78M | 1.71M | 1.69M | 1.66M |
EPS (Basic) | -49.35 | -26.67 | -5.59 | -61.7 | -22.91 | -3.07 | -0.02 | 0.37 | -8.57 | 5.67 | -6.3 |
EPS (Diluted) | -49.35 | -26.67 | -5.59 | -61.7 | -22.91 | -3.07 | -0.02 | 0.37 | -8.57 | 5.61 | -6.3 |
EBITDA | -263.54M | -219.64M | -5.88M | -826K | -104.37M | -10.52M | 11.29M | -20.07M | -9.37M | 1.16M | -1.68M |
EBIT | -462.2M | -245.9M | -37.08M | -4.63M | -103.1M | -621K | 14.28M | 16.21M | -24.31M | 12.64M | -10.6M |
Depreciation & Amortization | 26.74M | 27.25M | 27.66M | 26.42M | 25.34M | 20.09M | 19.04M | 18.7M | 16.95M | 7.95M | 5.85M |